Daiichi Sankyo Acquires Plexxikon for $935,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    91 Bolivar Drive Berkeley, CA 94710
  • Company Description
    Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas, including metabolic disease, oncology, inflammation, CNS and cardiovascular disease.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The purchase price for Plexxikon is $805 million up-front. Near-term milestone payments associated with the approval of PLX4032 could total an additional $130 million.

Trending on Xconomy